CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 126 enrolled
Drug / intervention
Acetaminophen 500Mg Cap +2 moredrug
Likely dose
Acetaminophen 500Mg Capfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03469310
NCT03469310Phase 4Completed

Minimizing Narcotic Analgesics After Thyroid or Parathyroid Surgery

Minerva A Romero Arenas·interventional·Posted Mar 19, 2018·Updated May 11, 2021

In Brief

A Phase 4 clinical trial evaluating Acetaminophen 500Mg Cap, Tylenol #3 Oral Tablet, and 1 other intervention for Thyroid Cancer and 7 related conditions. Completed, enrolled 126 participants across 1 site.

Detailed Summary

This research is being done to better understand and test if the investigators can minimize narcotic medication for controlling pain after thyroid or parathyroid surgery. This research will be performed at Doctors Hospital At Renaissance in the investigators clinic and the perioperative area. Participants will be randomly chosen to receive one of two options for pain management that the investigators are already using in the care of patients after surgery. One option includes a narcotic medication and one option includes a non-narcotic and a narcotic as needed. Participants will be asked to complete a form about the level of pain and how much pain medication was needed after surgery in the hospital and while at home. Participants will not have to do any additional visits to participate in this study. The investigators will obtain the research materials at the same time as the usual care visits around the participants' surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedMar 19, 2018
Enrollment StartMar 9, 2018
Primary CompletionDec 21, 2019
Study CompletionOct 2, 2020
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 8.3 years ago

Interventions

Acetaminophen 500Mg Capdrug

non-narcotic medication first with narcotic as second choice

Tylenol #3 Oral Tabletdrug

Narcotic medication first

Tramadoldrug

non-narcotic medication first with narcotic as second choice